Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Ä¡ÇÙÀýÁ¦¼úÈÄ ÇÕº´Áõ¿¡ ´ëÇÑ º£´ÏÅç(Venitol®)ÀÇ ÀÓ»óÀû È¿°ú ¹«ÀÛÀ§ ÇÒ´ç, À§¾à´ëÁ¶½ÃÇè Clinical Effects of Venitol® on Complications after Hemorrhoidectomy Prospective Randomized and Placebo-controlled Trial

´ëÇÑ´ëÀåÇ×¹®ÇÐȸÁö 1998³â 14±Ç 4È£ p.761 ~ 766
ÀÌÈï¿ì, ÀÌ¿ì¿ë, ÀüÈ£°æ,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÈï¿ì ( Lee Heung-Woo ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ¿Ü°úÇб³½Ç

ÀÌ¿ì¿ë ( Lee Woo-Yong ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ¿Ü°úÇб³½Ç
ÀüÈ£°æ ( Chun Ho-Kyung ) 
¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ¿Ü°úÇб³½Ç

Abstract


Fifty four patients who received closed hemorrhoidectomy were randomized into two parallel groups and treated with Venitol®(a micronized flavonoidic fraction containing diosmin 450 mg and hesperidin 50 mg) (group 1) or placebo (group 2). Venitol® was administered at the dosage of three toblets b.i.d. the first four days and two tablets b.i.d following three days. Postoperative analgesia and laxative prescription as well as hospital stay were same in two groups. Though there is no difference of symptoms at D1, improvement of symptoms of complications was greater in group 1 than in group 2 at D18. The clinical severity of postoperative spot-bleeding, pain and anal discharge diminished in both groups but to a greater extent in group 1 (P£¼0.005). There was no side-effects in using Venitol®. In summary, Venitol® is effective in reducing complications after hemorrhoidectomy.

Å°¿öµå

Venitol;Hemorrhoidectomy;Bleeding

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS